Halogem-P Ointment contains Halobetasol 0.05% w/w, a potent topical corticosteroid indicated for the treatment of various inflammatory and pruritic dermatoses responsive to corticosteroids, including psoriasis, eczema, and dermatitis. Halobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating the release of inflammatory mediators and suppressing immune responses in the affected skin. The ointment formulation ensures enhanced skin penetration and prolonged contact time, facilitating effective symptom relief. Halogem-P is typically applied in a thin layer to the affected area once or twice daily, as directed by a healthcare professional, and treatment duration should be limited to avoid potential adverse effects such as skin atrophy, telangiectasia, or systemic absorption leading to hypothalamic-pituitary-adrenal axis suppression. It is contraindicated in patients with hypersensitivity to halobetasol or any component of the formulation, and caution is advised when used on large surface areas, broken or infected skin. Patients should avoid occlusive dressings unless prescribed. Halogem-P Ointment is intended for external use only and should be kept out of reach of children. Consultation with a healthcare provider is recommended prior to use, especially in pediatric, pregnant, or lactating patients.